Flagship Biotech International Pvt Ltd
Since our establishment in the year 2008, we, Flagship Biotech International Private Limited, a Private Limited Company based in Navi Mumbai, Maharashtra, are known in the industry as the leading manufacturer and exporter of Antibacterial Medicine, Anesthetic Injection, Antibacterial Injection, Anti Diabetics Tablets, Pharmaceutical Injection, Anti Acid Medicine, Analgesic Injection, Anti Coagulant, Antidote Medicine, Antiemetic Syrup, Anti Fungal, Anti Histamines, Anti Helminthics, Anti Malarial, Anti-TB, Anti Viral, Cardiovascular System, Cytoprotective Agent, Diuretics Drugs, Eye And Ear Preparation, Haematinic Medicines, Intravenous And Other Sterile Solution, Laxative Tablets, Muscle Relaxant, Nasal Preparation, NSAIDs Drugs, Topical Anti-infectives, Veterinary Product, Vitamin Wheel, Antipsychotic Medications and Proton Pump Inhibitor. The entire range of products is formulated using superior grade ingredients and latest techniques. We export our products to Latin America, Africa, etc
|Nature of Business||Manufacturer|
|Ownership Type||Private Limited Company|
|Company CEO||Mr. Shailesh Patel|
|Registered Address||1204 & 1302, Rupa Solitaire, Plot A1, Sector 1, Millennium Business park, Mahape, Navi Mumbai –400710, Maharashtra, India., Mumbai –400710, Maharashtra, India., Mumbai Maharashtra 400710|
|Total Number of Employees||51 to 100 People|
|Year of Establishment||2008|
|Legal Status of Firm||1|
|Annual Turnover||Rs. 50 - 100 Crore|
Our company is a very trusted firm engaged in delivering a high quality range of products. All our products are precisely formulated under the strict guidance of domain experts at our advanced production unit.
Factors that help us become the leader in the market:
- Experienced team
- Modern infrastructure
- Hassle free payment modes
- Economical prices
We have WHO-c GMP Approved manufacturing plant.
Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
Awards and Achievements
It’s Immense Pleasure to announce that Flagship Biotech International awarded as Top 100 SME Award For the year 2015-16.
There were total 41000 Entries & Flagship Got Selected, based on Various Criteria such as Financial,3 years Performance in terms of People Capital, Innovation, International Outlook & Corporate Governance.
And also, chosen by Jury members comprising Several Industry Veterans Including Mr. Sunil Alagh(CEO of Britannia).
Mission / Vision
Provide quality generics for emerging markets at affordable prices using Global Standards.
Gain leadership positions in Acute & Chronic specialty therapies in India & other Developing Nations.
Flagship biotech creates value by executing a comprehensive business strategy guided by the following Core belief: